Clinical Study

Adding Streptomycin to an Intensified Regimen for Tuberculous Meningitis Improves Survival in HIV-Infected Patients

Table 1

Baseline characteristics by treatment group.

Standard ATTIntensified ATTIntensified ATT + STM value

Gender0.19
 Male52 (65.82)86 (72.27)25 (83.33)
 Female27 (34.18)33 (27.73)5 (16.67)
On ART0.004
 No53 (67.09)89 (74.79)13 (43.33)
 Yes26 (32.91)30 (25.21)17 (56.67)
Age (years), median (IQR)36.3 (31.6–45.3)37.1 (30.9–50)33.2 (30–40.4)0.33
Albumin (g/dL), median (IQR)3.5 (2.7–4)3.4 (2.9–3.9)3.7 (3.1–4.4)0.21
CD4 count (cells/μL), median (IQR)86 (45–174)102 (47–173)103 (58–169)0.65

ART, antiretroviral therapy; ATT, antituberculosis therapy; IQR, interquartile range; STM, streptomycin.
Data are presented as number (%) unless otherwise indicated. values were calculated using chi2 test for categorical variables and Kruskal-Wallis rank test for continuous variables.